<DOC>
	<DOCNO>NCT01984190</DOCNO>
	<brief_summary>Venous thromboembolic event ( VTE ) , either deep vein thrombose pulmonary embolus , important complication patient undergo knee hip arthroplasty . This multicenter Clinical Registry aim collect large volume clinical effectiveness data ActiveCare+S.F.T速 mobile compression device +/- aspirin lower potential risk venous thromboembolism ( VTE ) prophylaxis patient undergo primary low extremity total joint arthroplasty . The result compare pharmacology protocol .</brief_summary>
	<brief_title>Multicenter Registry Effectiveness Analysis ActiveCare+S.F.T速 Mobile Compression Device Thrombosis Prevention Hip Knee Arthroplasty</brief_title>
	<detailed_description>Orthopaedic surgeon ten site United States participate registry collect postoperative venous thromboembolism incidence low extremity joint arthroplasty patient use mobile compression device . Patients include registry eighteen year age old undergoing primary unilateral hip arthroplasty ( include hip resurfacing ) primary unilateral knee arthroplasty ( include unicondylar knee arthroplasty ) use mobile compression device without aspirin venous thromboembolism prevention . Patients exclude schedule revision surgery , history venous thromboembolism , coagulation disorder , solid tumor malignancy within last five year , major surgery three month prior joint surgery . An attempt enroll every patient consecutively make institution patient meet inclusion criterion decline participation include . Use ActiveCare+S.F.T速 mobile compression device begin intra-operatively continue minimum 10 day . The decision use aspirin discretion surgeon . All patient evaluate within three month postoperatively , document evidence deep venous thrombosis pulmonary embolus . 1 . Registry Procedures - Patients complete 1 page questionnaire regard usage mechanical compression device . The de-identified information questionnaire enter web base computer database research coordinator ten sit . The web base registry create third party ( Global Visions Technology , Inc. ) . - Once study close enrollment data entry complete , database manager pull data web base registry import statistical software program analysis . - A power analysis find sample sizes 1500 device group drug group would sufficient achieve power excess 90 % detect non-inferiority margin difference venous thromboembolism proportion two group 1.0 % . In calculation , consider drug group venous thromboembolism rate 0.5 % 1.0 % device group venous thromboembolism rate take drug group rate +1.0 % null hypothesis inferiority . Power compute case actual device venous thromboembolism rate identical drug comparator rate . The test statistic use one-sided score test , significance level set 0.025 . - SPSS version 13.0 ( SPSS , Chicago , Illinois ) NCSS Version 7.1.21 ( NCSS LLC , Kaysville , Utah ) use analysis registry data . Means calculate describe continuous variable ( age , height , weight ) frequency calculate describe categorical variable ( surgery type , aspirin use , incidence symptomatic venous thromboembolism ) . Upper bind 97.5 % CIs calculate around observe venous thromboembolism rate difference mobile compression device drug comparator . 2 . Quality Factors - Institutional Review Board ( IRB ) approval obtain site . - Patient privacy protect per Health Insurance Portability Accountability Act ( HIPAA ) . Patients remain anonymous ; patient identifier purge data originate center . Patient care NOT affect way participation study . - Accounts set coordinator respective password security . A data entry guide distribute coordinator , give instruction enter variable . Additionally , coordinator require view instructional video online permit begin data entry registry . - Validation criterion set field data enter correct format ( eg , must enter four digit year , sex must enter `` M '' `` F '' , etc ) . Ranges construct minimize data entry error ( eg , `` number day device worn '' restrict number 0 15 ) . If require field leave blank , prompt come ask coordinator fill miss data . The record mark incomplete require field complete . Each 10 site access view data . - Periodic data check perform database manager , query field keep track enrollment go site . When study close , database lock database manager .</detailed_description>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<criteria>Adult patient ( Age &gt; 18 yr ) . Patient intend undergo elective primary unilateral total hip arthroplasty ( THA ) total knee arthroplasty ( TKA ) , unicondylar knee arthroplasty ( UKA ) . Patient use ActiveCare+S.F.T速 +/ aspirin venous thromboembolism ( VTE ) prevention ( Aspirin ( ASA ) prescribe discretion surgeon ) . Patient known coagulation disorder Patient currently treat anticoagulant medication . Patients current sign symptom history deep vein thrombosis ( DVT ) pulmonary embolism ( PE ) . Patients currently suffer solid tumor malignancy . Patients underwent major surgery procedure within 3 month prior participation registry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>venous thromboembolism</keyword>
	<keyword>deep vein thrombosis</keyword>
	<keyword>pulmonary embolus</keyword>
	<keyword>hip arthroplasty</keyword>
	<keyword>knee arthroplasty</keyword>
	<keyword>efficacy</keyword>
	<keyword>mobile compression device</keyword>
	<keyword>mechanical device</keyword>
	<keyword>prophylaxis .</keyword>
</DOC>